The cost of containing one case of measles: The economic impact on the public health infrastructure-Iowa, 2004

Pediatrics

Volumn 116, Issue 1, 2005, Pages

  Dayan, Gustavo H ^a,c   Ortega Sánchez, Ismael R ^a   LeBaron, Charles W ^a   Quinlisk, M Patricia ^b  

^a CENTERS FOR DIS CONTR AND PREV   (United States)

^b IOWA DEPARTMENT OF PUBLIC HEALTH   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Economic evaluation; Measles; Measles mumps rubella vaccines

Indexed keywords

MEASLES VACCINE;

ARTICLE; CONTROLLED STUDY; HEALTH CARE; HEALTH CARE COST; HEALTH CARE PERSONNEL; HUMAN; INFECTION CONTROL; MEASLES; PRIORITY JOURNAL; PUBLIC HEALTH; PUBLIC HEALTH SERVICE; UNITED STATES; VACCINATION; CONTACT EXAMINATION; ECONOMICS; EPIDEMIC; INDIA; PREVENTIVE HEALTH SERVICE; TRAVEL;

CONTACT TRACING; DISEASE OUTBREAKS; HEALTH CARE COSTS; HUMANS; IMMUNIZATION PROGRAMS; INDIA; IOWA; MEASLES; PUBLIC HEALTH; QUARANTINE; TRAVEL; VACCINATION;

EID: 32544436379     PISSN: 00314005     EISSN: 00314005     Source Type: Journal    
DOI: 10.1542/peds.2004-2512     Document Type: Article

References (21)

1. World Health Organization. Initiative for vaccine research: measles. Available at: www.who.int/vaccine_research/diseases/measles/en. Accessed April 12, 2005
2. Centers for Disease Control and Prevention. Epidemiology of measles - United States, 2001-2003. MMWR Morb Mortal Wkly Rep. 2004;53:713-716
3. Centers for Disease Control and Prevention. National, state, and urban area vaccination levels among children aged 19-35 months - United States, 2003. MMWR Morb Mortal Wkly Rep. 2004;53:658-661
4. Centers for Disease Control and Prevention. State Immunization Requirements 2001-2002. Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention; 2002
5. Centers for Disease Control and Prevention, National Vaccine Advisory Committee. Report of the NVAC Working Group on Philosophical Exemptions, Minutes of the National Vaccine Advisory Committee, January 13, 1998. Atlanta, GA: National Vaccine Program Office; 1998:1-5
6. Feikin D, Lezotte DC, Hamman RF, Salmon DA, Chen RT, Hoffman RF. Individual and community risks of measles and pertussis associated with personal exemptions to immunization. JAMA. 2000;284:3145-3150
7. World Health Organization. WHO Vaccine Preventable Diseases Monitoring System: 2004 global summary. Geneva, Switzerland: World Health Organization; 2003. Available at: www.who.int/vaccines/globalsummary/immunization. Accessed April 12, 2005
8. Centers for Disease Control and Prevention. Imported measles case associated with nonmedical vaccine exemption - Iowa, March 2004. MMWR Morb Mortal Wkly Rep. 2004;53:244-246
9. White CC, Koplan JP, Orenstein WA. Benefits and costs of immunization for measles, mumps and rubella. Am J Public Health. 1985;75:739-744
10. Hatziandreu EJ, Brown RE, Halpern MT. A Cost-Benefit Analysis of the Measles-Mumps-Rubella (MMR) Vaccine. Report From the Medical Technology Assessment and Policy Research Program. Arlington, VA: US Department of Health and Human Services, Centers for Public Health Research and Evaluation; 1994
11. Watson JC, Hadler SC, Dykewicz CA, Reef S, Phillips L. Measles, mumps, and rubella - vaccine use and strategies for elimination of measles, rubella, and congenital rubella syndrome and control of mumps: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 1998;47(RR-8):1-57
12. Zhou F, Reef S, Massoudi M, et al. An economic analysis of the current universal 2-dose measles-mumps-rubella vaccination program in the United States. J Infect Dis. 2004 ;189(suppl 1):S131-S145
13. Baughman AL, Williams WW, Atkinson WL, Cook LG, Collins MJ. The impact of college prematriculation immunization requirements on risk for measles outbreaks [published correction appears in JAMA. 1994;272:1822]. JAMA. 1994;272:1127-1132
14. Jansen VAA, Stollenwerk N, Jensen HV, Ramsay ME, Edmunds WJ, Rhodes CJ. Measles outbreaks in a population with declining vaccine uptake. Science. 2003;301:804
15. Public Health Laboratory Service. London measles outbreak. Commun Dis Rep CDR Wkly. March 28, 2002:12(13). Available at: www.hpa.org.uk/cdr/PDFfiles/ 2002/cdr1302.pdf. Accessed August 20, 2004
16. Coughlan S, Connell J, Cohen B, Jin L, Hall W. Suboptimal measles-mumps-rubella vaccination coverage facilitates an imported measles outbreak in ireland. Clin Infect Dis. 2002;35:84-86
17. McBrien J, Murphy J, Gill D, Cronin M, O'Donovan C, Cafferkey MT. Measles outbreak in Dublin, 2000. Pediatr Infect Dis J. 2002;22:580-584
18. Centers for Disease Control and Prevention. Measles epidemic attributed to inadequate vaccination coverage - Campania, Italy, 2002. MMWR Morb Mortal Wkly Rep. 2003;52:1044-1047
19. Sutter RW, Markowitz LE, Bennetch JM, Morris W, Zell ER, Preblud SR. Measles among the Amish: a comparative study of measles severity in primary and secondary cases in households. J Infect Dis. 1991;163:12-16
20. van den Hof S, Meffre CM, Conyn-van Spaendonck MA, Woonink F, de Melker HE, van Binnendijk RS. Measles outbreak in a community with very low vaccine coverage, the Netherlands. Emerg Infect Dis. 2001;7(3 suppl):593-597
21. Robertson SE, Markowitz LE, Berry DA, Dini EF, Orenstein WA. A million dollar measles outbreak: epidemiology, risk factors, and a selective revaccination strategy. Public Health Rep. 1992;107:24-31